There are four viruses going around Britain – which one have you got?

With this year’s ‘quad-demic’ of flu, Covid, RSV and norovirus starting to surge, here are the symptoms to watch for and how ...
The Manila Times

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
TipRanks on MSN

Cocrystal Pharma reports Q3 EPS (19c) vs (49c) last year

We expect to begin enrolling participants in the first quarter of 2026 for our norovirus challenge study evaluating CDI-988, our oral ...

Vaxart, Inc.: Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollm ...